UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest reported) June 21, 2002
Advanced Biotherapy, Inc.
| Delaware | 0-26323 | 95-0402415 | ||
|
|
|
|
||
| (State or other jurisdiction | (Commission | (IRS Employer | ||
| of incorporation) | File Number) | Identification No.) |
|
6355 Topanga Canyon Boulevard, Suite
510
Woodland Hills, California |
91367 | |
|
|
|
|
|
(Address of principal executive offices)
|
(Zip
Code)
|
|
|
|
Registrant’s telephone number, including area code (818) 883-6716
| Item 5. OTHER EVENTS. | ||||||||
| Item 7. FINANCIAL STATEMENTS AND EXHIBITS | ||||||||
| Signatures | ||||||||
| INDEX TO EXHIBITS | ||||||||
| EXHIBIT 99.1 | ||||||||
Item 5. OTHER EVENTS.
The registrant published a press release on June 20, 2002, which reported that its Chief Executive Officer and President, Mr. Edmond Buccellato, was interviewed by the Wall Street Reporter. The content of that interview is available to be heard for approximately one week by logging-in at www.wallstreetreporter.com under “CEO Interviews.”
Item 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits.
| Designation | Description of Exhibit | |
| 99.1 | Press Release, dated June 20, 2002 |
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ADVANCED BIOTHERAPY,
INC. (Registrant) |
||
| Date: June 21, 2002 | By: /s/ Edmond Buccellato | |
|
Edmond Buccellato, President and CEO |
||
INDEX TO EXHIBITS
| Exhibit |
Description
|
|
|
99.1
|
Text of Press Release, dated June 20, 2002 |